Search results
Results from the WOW.Com Content Network
Broken down into ab-ci-xi-mab, its name shows the drug to be a chimeric monoclonal antibody used on the cardiovascular system. This and the following two names would look the same if the 2009 convention were applied. [37] The name of the breast cancer medication trastuzumab can be analyzed as tras-tu-zu-mab. Therefore, the drug is a humanized ...
These codes differ in terminology, and there is a long-term project to "harmonize" this. For instance, the ICN uses "valid" in "valid publication of a name" (=the act of publishing a formal name), with "establishing a name" as the ICZN equivalent. The ICZN uses "valid" in "valid name" (="correct name"), with "correct name" as the ICN equivalent ...
homonym: names spelled identically, but, in some codes, names spelled similarly, as defined by the code senior homonym (zoology): the first legitimate use of the name which generally takes priority; junior homonym (zoology), later homonym (botany): a later and generally illegitimate use, though in some circumstances the later name is allowed to ...
Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs.In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are brand names. [1]
Doss porphyria/ALA dehydratase deficiency/Plumboporphyria (the disease is known by multiple names) ALD Alcoholic liver disease: ALI Acute lung injury: ALL Acute lymphoblastic lymphoma, acute lymphocytic leukemia: ALS Amyotrophic lateral sclerosis: AMD Age-related macular degeneration: AML Acute myelogenous leukemia: AN Anorexia nervosa: AOCD
Each bacterial gene is denoted by a mnemonic of three lower case letters which indicate the pathway or process in which the gene-product is involved, followed by a capital letter signifying the actual gene. In some cases, the gene letter may be followed by an allele number. All letters and numbers are underlined or italicised.
Australia decided not to use a 4-letter suffix. [23] [24] [25] A version of the four-letter suffix has been proposed to the WHO as the biological qualifier (BQ). It is not part of the international nonproprietary name (INN), but is proposed to be managed under the same registry. [26]
An International Nonproprietary Name (INN) is an official generic and nonproprietary name given to a pharmaceutical substance or an active ingredient, [1] encompassing compounds, peptides and low-molecular-weight proteins (e.g., insulin, hormones, cytokines), as well as complex biological products, such as those used for gene therapy. [2]